Drug Development Cancer Treatment Regenerative Medicine Targeted Therapy Immunotherapy Drug Discovery Natural Therapies Pharmacology Innovative Treatments Chronic Conditions Topical Treatments Treatment Development Targeted Treatments Disease Treatment Viral Infections Microbiome Therapy Antiviral Therapies Symptomatic Treatments Microbiome Cardiovascular Health Memory Treatment Disease Intervention Metabolic Therapies Rehabilitation Pharmaceuticals Drug Formulations Immunomodulation Diabetes Treatment Treatment Indications Treatment Strategies Non-invasive Treatments Cardiology Obesity Treatments Treatment Methods Biotechnology Microbiome-based Therapies Cell Therapy Mitochondrial Disorders Cardiology Treatments Nanobody Therapy Biotherapeutics Osteoarthritis Obesity Monoclonal Antibodies Neuropsychiatric Symptoms Phage Therapy Cancer Therapy RNA Medicine Precision Medicine Pain Treatment Neurostimulation Metabolic Diseases Protein Therapy Microbiota-Based Therapies GLP-1 Therapies Combination Therapy Amylin Analog
The peer-reviewed study identifies pseudaminic acid as a selective target for passive immunotherapy that also enables pathogen mapping.
